% Cemiplimab for non-small cell lung cancer: Does it work? Health ConditionsHealth ConditionsAlzheimer's & DementiaAnxietyArthritisAsthma & AllergiesBreast CancerCancerCardiovascular HealthCOVID-19Dermatology & SkincareDiabetesEnvironment & SustainabilityExercise & FitnessEye HealthHeadache & MigraineHealth EquityHIV & AIDSHuman BiologyInflammatory Bowel DiseaseLeukemiaLGBTQIA+Men's HealthMental HealthMultiple Sclerosis (MS)NutritionParkinson's DiseasePsoriasisSexual HealthWomen's HealthDiscoverNewsLatest NewsOriginal SeriesMedical MythsHonest NutritionThrough My EyesNew Normal HealthPodcastsHow to understand chronic painWhat is behind vaccine hesitancy?The amazing story of hepatitis C, from discovery to cureNew directions in dementia researchCan psychedelics rewire a depressed, anxious brain?Why climate change matters for human healthToolsGeneral HealthDrugs A-ZHealth HubsHealth ToolsBMI Calculators and ChartsBlood Pressure Chart: Ranges and GuideBreast Cancer: Self-Examination GuideSleep CalculatorHealth ProductsAffordable Therapy OptionsBlood Pressure MonitorsDiabetic SuppliesFitness TrackersHome GymsGreen Cleaning ProductsHow to Shop for CBDQuizzesRA Myths vs FactsType 2 Diabetes: Managing Blood SugarAnkylosing Spondylitis Pain: Fact or FictionConnectAbout Medical News TodayWho We AreOur Editorial ProcessContent IntegrityConscious LanguageNewslettersSign UpFollow UsMedical News TodayHealth ConditionsDiscoverToolsConnectSubscribe
Does cemiplimab work for non-small cell lung cancer Medically reviewed by Teresa Hagan Thomas PHD, BA, RN — By Zawn Villines on May 30, 2022Cemiplimab is a type of immunotherapy that may help in the treatment of non-small cell lung cancer (NSCLC). However, this type of cancer is still usually fatal.
thumb_upLike (48)
commentReply (2)
shareShare
visibility845 views
thumb_up48 likes
comment
2 replies
J
Julia Zhang 2 minutes ago
In 2021, the Food and Drug Administration (FDA) approved cemiplimab for advanced NSCLC. It is a type...
R
Ryan Garcia 2 minutes ago
For example, a 2020 clinical trial that helped give rise to the FDA approval found a median overall ...
D
David Cohen Member
access_time
10 minutes ago
Saturday, 03 May 2025
In 2021, the Food and Drug Administration (FDA) approved cemiplimab for advanced NSCLC. It is a type of immunotherapy that the FDA previously approved for squamous cell skin cancer. Several studies suggest that cemiplimab, which Regeneron Pharmaceuticals markets as Libtayo, can help kill NSCLC cells and prolong survival.
thumb_upLike (14)
commentReply (2)
thumb_up14 likes
comment
2 replies
A
Ava White 2 minutes ago
For example, a 2020 clinical trial that helped give rise to the FDA approval found a median overall ...
N
Natalie Lopez 5 minutes ago
When the disease progresses, curing it becomes more difficult, so doctors focus on prolonging surviv...
D
Dylan Patel Member
access_time
3 minutes ago
Saturday, 03 May 2025
For example, a 2020 clinical trial that helped give rise to the FDA approval found a median overall survival of 22.1 months with cemiplimab, compared with 14.3 months with just chemotherapy. The drug can treat advanced NSCLC, which has a poor outlook. The goal of treatment with earlier stages of NSCLC is to cure the disease.
thumb_upLike (42)
commentReply (2)
thumb_up42 likes
comment
2 replies
C
Chloe Santos 3 minutes ago
When the disease progresses, curing it becomes more difficult, so doctors focus on prolonging surviv...
E
Ella Rodriguez 1 minutes ago
What is cemiplimab
Share on PinterestCIPhotos/Getty ImagesCancer happens when cells grow out of con...
L
Lucas Martinez Moderator
access_time
16 minutes ago
Saturday, 03 May 2025
When the disease progresses, curing it becomes more difficult, so doctors focus on prolonging survival. Cemiplimab works to prolong survival. Read on to learn about cemiplimab for NSCLC, including how effective it is, the risks and benefits, and some alternative treatment methods.
thumb_upLike (7)
commentReply (2)
thumb_up7 likes
comment
2 replies
J
Jack Thompson 14 minutes ago
What is cemiplimab
Share on PinterestCIPhotos/Getty ImagesCancer happens when cells grow out of con...
A
Aria Nguyen 6 minutes ago
This can slow the growth and spread of cancer. According to a 2021 study, cemiplimab works by helpin...
M
Madison Singh Member
access_time
5 minutes ago
Saturday, 03 May 2025
What is cemiplimab
Share on PinterestCIPhotos/Getty ImagesCancer happens when cells grow out of control, evading the immune system’s ability to kill the harmful, rapidly growing cells. Cemiplimab is a type of immunotherapy. This means that it supports the immune system to recognize and kill cancer cells.
thumb_upLike (46)
commentReply (0)
thumb_up46 likes
B
Brandon Kumar Member
access_time
24 minutes ago
Saturday, 03 May 2025
This can slow the growth and spread of cancer. According to a 2021 study, cemiplimab works by helping the immune system recognize NSCLCs that contain the protein anti-programmed cell death ligand-1 (PD-L1). PD-L1 is present on some, but not all, NSCLC cells.
thumb_upLike (33)
commentReply (1)
thumb_up33 likes
comment
1 replies
H
Henry Schmidt 15 minutes ago
It prevents normal cell death and allows cancer to grow out of control. By helping the immune system...
D
David Cohen Member
access_time
21 minutes ago
Saturday, 03 May 2025
It prevents normal cell death and allows cancer to grow out of control. By helping the immune system recognize and target PD-L1, cemiplimab supports the body to kill NSCLC. Research on cemiplimab has focused on people with more than 50% of their cancer cells testing positive for PD-L1.
thumb_upLike (9)
commentReply (0)
thumb_up9 likes
A
Ava White Moderator
access_time
8 minutes ago
Saturday, 03 May 2025
It may not be an option for people with other types of NSCLC. Cemiplimab can be a first-line treatment, which means that a person does not have to try other treatments first. Does cemiplimab work as a treatment for NSCLC
Cemiplimab improves outcomes in people with NSCLC.
thumb_upLike (29)
commentReply (1)
thumb_up29 likes
comment
1 replies
J
Julia Zhang 7 minutes ago
Advanced NSCLC, however, is typically fatal. The manufacturer of cemiplimab markets it as a drug to ...
E
Emma Wilson Admin
access_time
27 minutes ago
Saturday, 03 May 2025
Advanced NSCLC, however, is typically fatal. The manufacturer of cemiplimab markets it as a drug to live longer, not a cure.
thumb_upLike (19)
commentReply (1)
thumb_up19 likes
comment
1 replies
M
Madison Singh 23 minutes ago
Cemiplimab does live up to this promise, based on clinical trials. In a stage 3 clinical trial that ...
A
Alexander Wang Member
access_time
10 minutes ago
Saturday, 03 May 2025
Cemiplimab does live up to this promise, based on clinical trials. In a stage 3 clinical trial that compared the drug with chemotherapy, cemiplimab participants had a median survival of 22.1 months, compared with 14.3 months with just chemotherapy.
thumb_upLike (50)
commentReply (2)
thumb_up50 likes
comment
2 replies
E
Emma Wilson 2 minutes ago
The drug is relatively new and gained FDA approval in 2021. More research might identify additional ...
E
Emma Wilson 5 minutes ago
However, people considering this drug should know that side effects are common and often unpleasant....
A
Aria Nguyen Member
access_time
22 minutes ago
Saturday, 03 May 2025
The drug is relatively new and gained FDA approval in 2021. More research might identify additional uses, ways to make the drug more effective, or additional drug combinations.
thumb_upLike (32)
commentReply (2)
thumb_up32 likes
comment
2 replies
L
Lily Watson 8 minutes ago
However, people considering this drug should know that side effects are common and often unpleasant....
E
Ella Rodriguez 8 minutes ago
For many people with cancer, the cost of treatment can be a barrier. It may also pose a problem for ...
C
Chloe Santos Moderator
access_time
24 minutes ago
Saturday, 03 May 2025
However, people considering this drug should know that side effects are common and often unpleasant. It is important to talk with a doctor about the risks and benefits of treatment and a strategy for managing side effects.
thumb_upLike (29)
commentReply (2)
thumb_up29 likes
comment
2 replies
L
Lily Watson 16 minutes ago
For many people with cancer, the cost of treatment can be a barrier. It may also pose a problem for ...
J
Joseph Kim 11 minutes ago
NSCLC vs other lung cancer
NSCLC means that, under a microscope, the cells look larger than they do...
A
Audrey Mueller Member
access_time
26 minutes ago
Saturday, 03 May 2025
For many people with cancer, the cost of treatment can be a barrier. It may also pose a problem for taxpayers and insurers covering treatment. A 2021 study suggests that cemiplimab is a cost effective treatment option, with cost effectiveness increasing as the number of PD-L1 cells on the cancer increases.
thumb_upLike (28)
commentReply (3)
thumb_up28 likes
comment
3 replies
D
Daniel Kumar 20 minutes ago
NSCLC vs other lung cancer
NSCLC means that, under a microscope, the cells look larger than they do...
A
Amelia Singh 13 minutes ago
However, overall lung cancer survival is higher with NSCLC. According to the American Cancer Society...
NSCLC vs other lung cancer
NSCLC means that, under a microscope, the cells look larger than they do when compared with small cell lung cancer. Smoking is a risk factor for developing both NSCLC and small cell lung cancer. NSCLC includes three subsets of cancer: adenocarcinoma: cancer that forms in the glands that secrete mucus into the lungs; the most common type of NSCLC and most common type of lung cancerlarge cell carcinoma: a group of NSCLC with larger cells compared with the other forms of NSCLCsquamous cell carcinoma: NSCLC that begins in the cells that line the bronchi of the lungs
Survival rates for both types of cancer are low, especially in the later stages of cancer, when doctors often discover a tumor.
thumb_upLike (6)
commentReply (3)
thumb_up6 likes
comment
3 replies
G
Grace Liu 7 minutes ago
However, overall lung cancer survival is higher with NSCLC. According to the American Cancer Society...
J
James Smith 8 minutes ago
For NSCLC, it is 26%. Risks and side effects
According to the manufacturer, the most common side eff...
However, overall lung cancer survival is higher with NSCLC. According to the American Cancer Society, the 5-year survival rate for all combined stages of small cell lung cancer is 7%.
thumb_upLike (41)
commentReply (1)
thumb_up41 likes
comment
1 replies
M
Mia Anderson 7 minutes ago
For NSCLC, it is 26%. Risks and side effects
According to the manufacturer, the most common side eff...
H
Harper Kim Member
access_time
64 minutes ago
Saturday, 03 May 2025
For NSCLC, it is 26%. Risks and side effects
According to the manufacturer, the most common side effects in clinical trials and the percentages of participants who experienced them are as follows:fatigue: 34%rash: 31%diarrhea: 25%bone or muscle pain: 24%nausea: 21%itching: 18%cough: 14%constipation: 13%joint pain: 11%anemia: 11%vomiting: 10%hypothyroidism: 10%loss of appetite: 10%
Alternative treatment options
Chemotherapy was the standard treatment for people with advanced NSCLC prior to cemiplimab. This may be an option for people who do not want to use cemiplimab or whose bodies do not respond well to the drug.
thumb_upLike (17)
commentReply (2)
thumb_up17 likes
comment
2 replies
E
Elijah Patel 36 minutes ago
In people who have stage 1, 2, or 3 cancer, the goal of treatment is to cure the disease. Cemiplimab...
L
Lily Watson 49 minutes ago
Instead, surgery to remove the cancer, as well as part of the lung, may cure the disease. A person m...
N
Nathan Chen Member
access_time
85 minutes ago
Saturday, 03 May 2025
In people who have stage 1, 2, or 3 cancer, the goal of treatment is to cure the disease. Cemiplimab is not typically an option in these cases.
thumb_upLike (15)
commentReply (3)
thumb_up15 likes
comment
3 replies
R
Ryan Garcia 44 minutes ago
Instead, surgery to remove the cancer, as well as part of the lung, may cure the disease. A person m...
M
Mia Anderson 49 minutes ago
Without taking into account the type of NSCLC or the treatment a person has, the American Cancer Soc...
Instead, surgery to remove the cancer, as well as part of the lung, may cure the disease. A person may then require chemotherapy, radiation, or both. Outlook
The long-term outlook for NSCLC is not favorable, though it tends to improve with cemiplimab.
thumb_upLike (26)
commentReply (1)
thumb_up26 likes
comment
1 replies
L
Luna Park 37 minutes ago
Without taking into account the type of NSCLC or the treatment a person has, the American Cancer Soc...
C
Christopher Lee Member
access_time
57 minutes ago
Saturday, 03 May 2025
Without taking into account the type of NSCLC or the treatment a person has, the American Cancer Society reports the following percentages of people with NSCLC who are alive after 5 years: localized NSCLC: 64%regional: 37%distant: 8%
Cemiplimab is specifically for NSCLC that is advanced and for which surgery is not an option. This is usually cancer that:has spreadis in someone who cannot undergo chemotherapyis in someone who is too sick for surgery
In stage 3 clinical trials, the median survival with cemiplimab was 22.1 months, compared with 14.3 months with chemotherapy.
thumb_upLike (44)
commentReply (3)
thumb_up44 likes
comment
3 replies
W
William Brown 48 minutes ago
Summary
Cemiplimab may help people with NSCLC live longer, but it is not a cure. Living longer, howe...
N
Natalie Lopez 39 minutes ago
However, cemiplimab can cause serious side effects similar to other cancer treatments. For this reas...
Summary
Cemiplimab may help people with NSCLC live longer, but it is not a cure. Living longer, however, means more time to join clinical trials if a person wants to try experimental treatments. It can also mean more time with friends and family.
thumb_upLike (5)
commentReply (2)
thumb_up5 likes
comment
2 replies
S
Scarlett Brown 49 minutes ago
However, cemiplimab can cause serious side effects similar to other cancer treatments. For this reas...
H
Henry Schmidt 43 minutes ago
A person can talk with an oncologist to explore treatment options and assess whether a cure is possi...
Z
Zoe Mueller Member
access_time
63 minutes ago
Saturday, 03 May 2025
However, cemiplimab can cause serious side effects similar to other cancer treatments. For this reason, a person should weigh the risks and side effects of treatment against the potential benefits. For some people, focusing on comfort may be a better choice that empowers them to enjoy their life.
thumb_upLike (18)
commentReply (1)
thumb_up18 likes
comment
1 replies
S
Sebastian Silva 10 minutes ago
A person can talk with an oncologist to explore treatment options and assess whether a cure is possi...
S
Sophie Martin Member
access_time
44 minutes ago
Saturday, 03 May 2025
A person can talk with an oncologist to explore treatment options and assess whether a cure is possible. If it is not, cemiplimab might be a good alternative. Last medically reviewed on May 30, 2022UncategorizedMedically reviewed by Teresa Hagan Thomas PHD, BA, RN — By Zawn Villines on May 30, 2022
Latest newsWhat sets 'SuperAgers' apart?
thumb_upLike (48)
commentReply (3)
thumb_up48 likes
comment
3 replies
A
Amelia Singh 24 minutes ago
Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affecti...
L
Luna Park 40 minutes ago
Learn more about how this treatment works in people with lung cancer.READ MORESmall cell vs. non-sma...
Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affective disorder (SAD): How to beat it this fall and winterCDC: Monkeypox in the US 'unlikely to be eliminated in the near future'Why are more women prone to Alzheimer's? New clues arise
Related CoverageEverything to know about non-small cell lung cancerMedically reviewed by Raj Dasgupta, MD
Non-small cell lung cancer is the most common type of lung cancer. Learn about its different stages and treatment options here.READ MOREHow it works: Immunotherapy for advanced lung cancerMedically reviewed by Christina Chun, MPH
Immunotherapy treatment uses a person's immune system to attack cancer cells.
thumb_upLike (43)
commentReply (0)
thumb_up43 likes
A
Aria Nguyen Member
access_time
48 minutes ago
Saturday, 03 May 2025
Learn more about how this treatment works in people with lung cancer.READ MORESmall cell vs. non-small cell lung cancerMedically reviewed by Seunggu Han, MD
The two main types of lung cancer are small cell and non-small cell lung cancer.
thumb_upLike (48)
commentReply (3)
thumb_up48 likes
comment
3 replies
I
Isabella Johnson 4 minutes ago
Learn about the symptoms, diagnosis, treatments, and outlook for each…READ MOREDoes immunotherapy ...
E
Ella Rodriguez 25 minutes ago
Learn more about how it works…READ MOREWhat to know about metastatic non-small cell lung cancer
No...
Learn about the symptoms, diagnosis, treatments, and outlook for each…READ MOREDoes immunotherapy work for small cell lung cancer?Medically reviewed by Adithya Cattamanchi, M.D. Doctors are using certain types of immunotherapy to treat several conditions, including small cell lung cancer (SCLC).
thumb_upLike (37)
commentReply (2)
thumb_up37 likes
comment
2 replies
A
Audrey Mueller 45 minutes ago
Learn more about how it works…READ MOREWhat to know about metastatic non-small cell lung cancer
No...
B
Brandon Kumar 54 minutes ago
Cemiplimab for non-small cell lung cancer: Does it work? Health ConditionsHealth ConditionsAlzheimer...
K
Kevin Wang Member
access_time
130 minutes ago
Saturday, 03 May 2025
Learn more about how it works…READ MOREWhat to know about metastatic non-small cell lung cancer
Non-small cell lung cancer (NSCLC) refers to later stages of cancer where it has spread to distant parts of the body. Learn more.READ MORE
thumb_upLike (9)
commentReply (2)
thumb_up9 likes
comment
2 replies
E
Evelyn Zhang 47 minutes ago
Cemiplimab for non-small cell lung cancer: Does it work? Health ConditionsHealth ConditionsAlzheimer...
N
Nathan Chen 88 minutes ago
In 2021, the Food and Drug Administration (FDA) approved cemiplimab for advanced NSCLC. It is a type...